B-ALL Risk Stratification
Acute lymphoblastic leukemia (acute lymphocytic leukemia, ALL) is a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. The whole genome sequencing of different...
Know more about this package
Acute lymphoblastic leukemia (acute lymphocytic leukemia, ALL) is a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. The whole genome sequencing of...
Understanding B-ALL Risk Stratification
Acute lymphoblastic leukemia (acute lymphocytic leukemia, ALL) is a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. The whole genome sequencing of different subtypes of leukemia has revealed new recurrent genetic and chromosomal abnormalities that add value to the existing prognostic scoring index in different subtypes of leukemia.
The scope of this B-ALL/T-ALL risk stratification gene panel testing includes scre...
What does B-ALL Risk Stratification measure?
Contains 19 testsB-ALL Risk Stratification includes ABL1, ATRX, CDKN2A, CREBBP, DNMT3A, ETV6, FBXW7, FLT3, and more.
Package contains 19 tests
Showing 8 of 19 tests, 11 more available
How does home sample collection work?
Search or choose
Find the right test or package.
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.